🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Authors
David M. Aboulafia

David M. Aboulafia

Virginia Mason Medical Center

ORCID: 0000-0002-6752-3530

Also affiliated with Jones Institute

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.271Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study

eLife(2023)10.7554/elife.82618

Top 58%

0.271DataRank

Top 58%3 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

Papers

Driven by 15 papers — median percentile 21. Top paper: “Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)”.

Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)

Blood(2020)10.1182/blood.2019003959

N/A

2.1DataRank · unranked

70 citations

Joseph A. Sparano, Amy Chadburn, Erin Reid, Richard F. Ambinder, Eric R. Siegel +13 more

AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-0645

N/A

0.560DataRank · unranked

15 citations

Kelly A. Shimabukuro, Page C. Moore, Richard F. Ambinder, Jack D. Bui, Semi Han +9 more

Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma

Haematologica(2020)10.3324/haematol.2019.243386

N/A

0.425DataRank · unranked

16 citations

Jeannette Y. Lee, Lawrence D. Kaplan, Juan Carlos Ramos, Richard F. Ambinder, William Wachsman +8 more

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study

eLife(2023)10.7554/elife.82618

Top 58%

0.271DataRank

Top 58%3 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

A phase 1b/pharmacokinetic trial of PTC299, a novel post-transcriptional VEGF inhibitor, for AIDS-related Kaposi’s sarcoma: AIDS Malignancy Consortium trial 059

UNC Libraries(2020)10.17615/q862-w217

N/A

0DataRank · unranked

1 citations

Anil Tulpule, Bruce J. Dezube, Dirk P. Dittmer, Rachel Bender Ignacio, Veenadhari Chavakula +13 more

Linguistic validation of the Spanish version of the Anal Cancer High-Grade squamous intraepithelial lesions outcomes Research Health-Related Symptom Index (A-HRSI): AMC-A04

Journal of Patient-Reported Outcomes(2022)10.1186/s41687-022-00515-1

N/A

0DataRank · unranked

2 citations

Kathleen Lynch, Jacqueline Vera, Nuria Mendoza Olivares, Andrew Webb, Lisa C. Diamond +12 more

Davids versus Goliaths: Pharma and academia threats to individual scientists and clinicians

The Journal of Scientific Practice and Integrity(2022)10.35122/001c.36564

N/A

0DataRank · unranked

2 citations

Nancy F. Olivieri, Shamia Hoque, David M. Aboulafia, Anne Ventrone, Courtney Lubaczewski +15 more

Construct validity and responsiveness of a health-related symptom index for persons either treated or monitored for anal high-grade squamous intraepithelial lesions (HSIL): AMC-A01/-A03

Quality of Life Research(2023)10.1007/s11136-023-03391-4

N/A

0DataRank · unranked

5 citations

Shelly Lensing, Jeannette Y. Lee, Di Chang, Soo Young Kim, Yuelin Li +30 more

Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087)

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1142

N/A

0DataRank · unranked

3 citations

Jeannette Y. Lee, Elizabeth Y. Chiao, David M. Aboulafia, Lee Ratner, Richard F. Ambinder +6 more

Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

The Medicine Forum(2023)10.1101/2023.03.09.23287038

Top 100%

0DataRank

Top 100%0 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

Hemostatic Disorders Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection, COVID-19 Vaccination, and Long-COVID Syndrome

Clinics in Laboratory Medicine(2025)10.1016/j.cll.2025.07.008

N/A

0DataRank · unranked

0 citations

David M. Aboulafia, Prakash Vishnu

Prognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective Study

Research Square(2025)10.21203/rs.3.rs-7607922/v1

N/A

0DataRank · unranked

0 citations

Brian L. Egleston, Zachary AK Frosch, Ralphael Steiner, Ariela Noy, Veronica Carvajal +42 more

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance

Cancer Cell(2020)10.1016/j.ccell.2020.10.022

N/A

0DataRank · unranked

33 citations

David M. Aboulafia, Melissa Accordino, Jared D. Acoba, Manmeet S. Ahluwalia, Syed A. Ahmad +95 more

Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions

The Lancet Oncology(2020)10.1016/s1470-2045(20)30485-x

N/A

0DataRank · unranked

30 citations

Martin W. Schoen, Shamia Hoque, Bartlett J. Witherspoon, David M. Aboulafia, Catherine S. Hwang +9 more

Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997–2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR)

EClinicalMedicine(2020)10.1016/j.eclinm.2020.100693

N/A

0DataRank · unranked

7 citations

Shamia Hoque, Nancy F. Olivieri, Matthew A. Taylor, David M. Aboulafia, Courtney Lubaczewski +29 more